Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjali Yadava

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2012
Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center inductionJames J Moon, Heikyung Suh, Adrienne V Li, et al.
The American Journal of Tropical Medicine and Hygiene|December 5, 2008
Positive rK39 serologic assay results in US servicemen with cutaneous leishmaniasisJoshua D Hartzell, Naomi E Aronson, Peter J Weina, et al.
Infection and Immunity|December 13, 2006
A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoitesAnjali Yadava, Jetsumon Sattabongkot, Michael A Washington, et al.
Plos Neglected Tropical Diseases|October 21, 2014
Protective efficacy of a Plasmodium vivax circumsporozoite protein-based vaccine in Aotus nancymaae is associated with antibodies to the repeat regionAnjali Yadava, Cysha E Hall, JoAnn S Sullivan, et al.
The Journal of Infectious Diseases|October 7, 2009
Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central AfricaRichard Culleton, Mathieu Ndounga, Fadile Yildiz Zeyrek, et al.
Vaccine|October 23, 2013
Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaquesYannick Vanloubbeeck, Sathit Pichyangkul, Babak Bayat, et al.
The New England Journal of Medicine|October 4, 2013
Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malariaJason W Bennett, Brandon S Pybus, Anjali Yadava, et al.
Vaccine|January 14, 2009
Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivaxBrian A Bell, James F Wood, Reeta Bansal, et al.
Infection and Immunity|December 19, 2018
Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic AntigensCysha E Hall, Lisa M Hagan, Elke Bergmann-Leitner, et al.
Vaccine|March 20, 2012
Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in miceJoanne M Lumsden, Saule Nurmukhambetova, Jennifer H Klein, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2012
Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center inductionJames J Moon, Heikyung Suh, Adrienne V Li, et al.
The American Journal of Tropical Medicine and Hygiene|December 5, 2008
Positive rK39 serologic assay results in US servicemen with cutaneous leishmaniasisJoshua D Hartzell, Naomi E Aronson, Peter J Weina, et al.
Infection and Immunity|December 13, 2006
A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoitesAnjali Yadava, Jetsumon Sattabongkot, Michael A Washington, et al.
Plos Neglected Tropical Diseases|October 21, 2014
Protective efficacy of a Plasmodium vivax circumsporozoite protein-based vaccine in Aotus nancymaae is associated with antibodies to the repeat regionAnjali Yadava, Cysha E Hall, JoAnn S Sullivan, et al.
The Journal of Infectious Diseases|October 7, 2009
Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central AfricaRichard Culleton, Mathieu Ndounga, Fadile Yildiz Zeyrek, et al.
Vaccine|October 23, 2013
Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaquesYannick Vanloubbeeck, Sathit Pichyangkul, Babak Bayat, et al.
The New England Journal of Medicine|October 4, 2013
Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malariaJason W Bennett, Brandon S Pybus, Anjali Yadava, et al.
Vaccine|January 14, 2009
Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivaxBrian A Bell, James F Wood, Reeta Bansal, et al.
Infection and Immunity|December 19, 2018
Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic AntigensCysha E Hall, Lisa M Hagan, Elke Bergmann-Leitner, et al.
Vaccine|March 20, 2012
Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in miceJoanne M Lumsden, Saule Nurmukhambetova, Jennifer H Klein, et al.
Pageof 3